LEU Centrus Energy Corp.
Centrus Energy Corp. supplies nuclear fuel components for the nuclear power industry in the United States, Japan, the Netherlands, and internationally. The company operates through two segments: Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants. The Technical Solutions segment offers technical, manufacturing, engineering, and operations services to public and private sector customers. It also operates as a equipment manufacturing and engineering firm focused primarily on the energy sector. Additionally, it manufactures and ships centrifuges to Oak Ridge to support a major expansion of its uranium enrichment capacity in Ohio. The company was formerly known as USEC Inc. and changed its name to Centrus Energy Corp. in September 2014. Centrus Energy Corp. was incorporated in 1998 and is headquartered in Bethesda, Maryland.…
Industry Peers
UraniumKey Statistics
About Centrus Energy (NYSE: LEU)
›
Centrus Energy (NYSE: LEU) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Uranium industry, part of the Energy sector, and reports about 467 employees.
The shares were at 89.70 USD on 19 November 2026, down 64.1% over 52 weeks. Its 52-week range is 84.90 USD to 345.60 USD: the price is 74.0% below the high and 5.6% above the low.
At a market capitalisation of 1.85B USD, it trades at 26.6 times trailing earnings and 20.3 times forward earnings. The median trailing P/E of its 8 largest Uranium peers is 80.5, a discount of 67% for LEU.
Centrus Energy reports return on equity of 10.2%, an operating margin of -2.8% and revenue down 25.9% year over year.
It holds more cash than debt, a net cash position of 1.06B USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 20 analysts cover the stock, with an average rating of Buy; their mean price target of 180.00 USD is 100.7% above the current price. The next earnings report is expected on 10 February 2027.